Stockscreener 앱 받기
4.915
2.08%
0.105
전일 마감가:
$4.81
열려 있는:
$4.87
하루 거래량:
1.45M
Relative Volume:
0.70
시가총액:
$1.84B
수익:
$10.53B
순이익/손실:
$-1.23B
주가수익비율:
-1.5142
EPS:
-3.246
순현금흐름:
$949.99M
1주 성능:
-0.41%
1개월 성능:
-8.57%
6개월 성능:
-37.85%
1년 성능:
-28.53%
1일 변동 폭
$4.85
$5.005
1주일 범위
$4.74
$5.005
52주 변동 폭
$4.565
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
명칭
Bausch Health Companies Inc
전화
514-744-6792
주소
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
4.915 | 1.80B | 10.53B | -1.23B | 949.99M | -3.246 |
TAK
Takeda Pharmaceutical Co Adr
|
16.95 | 53.37B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.84 | 42.80B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.58 | 41.09B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.86 | 31.62B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
558.90 | 23.23B | 3.17B | 1.29B | 1.01B | 27.09 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2024-08-02 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | 개시 | Raymond James | Mkt Perform |
| 2023-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | 다운그레이드 | Truist | Buy → Hold |
| 2022-07-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-06-13 | 재개 | JP Morgan | Overweight |
| 2021-03-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-02-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-24 | 개시 | Citigroup | Buy |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-02 | 개시 | Goldman | Neutral |
| 2019-10-25 | 개시 | Cowen | Outperform |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-08-15 | 업그레이드 | TD Securities | Hold → Buy |
| 2019-07-19 | 개시 | Wolfe Research | Outperform |
| 2019-06-11 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-01-02 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | 업그레이드 | Piper Jaffray | Underweight → Neutral |
모두보기
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Bausch Health plans July 29 call for Q2 results and business update - Stock Titan
Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026 - TradingView
Bausch Health Continues Specialty Pharma Strategy In 6 July 2026 - Kalkine Media
Why Did Bausch Health (TSX:BHC) Announce a Board Change? - Kalkine Media
Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia - Yahoo! Finance Canada
Bausch Health Companies (BHC) Posts Modest Gain, Tests Resistance ZoneETF AUM Growth - dars.gov.et
Bausch Health (BHC) director granted RSUs in lieu of cash fees - Stock Titan
Bausch Health (NYSE: BHC) director John Paulson granted 12,677 RSUs as board pay - Stock Titan
Bausch Health (NYSE: BHC) director granted 6,845 RSUs as board compensation - Stock Titan
Bausch Health (TSX:BHC) Board Change Follows Director Resignation - Kalkine Media
Best TSX Healthcare Stocks to Watch for July 2026 - Kalkine Media
Michael Goettler Resigns from Bausch Health's Board of Directors - The Globe and Mail
Director Michael Goettler exits Bausch Health (NYSE: BHC) board - Stock Titan
Bausch + Lomb survey finds dry eye affects emotional health By Investing.com - Investing.com South Africa
Why Is Bausch Health (TSX:BHC) Expanding Beyond the S&P/TSX? - Kalkine Media
BVF Forecast — Price Target — Prediction for 2027 - TradingView
Bausch Health (BHC) Drops Nearly 10%: Support Levels in Focus After Sharp DeclineMean Reversion Trade - dars.gov.et
Bausch Health Companies Inc. Actuals & Estimates (TSX:BHC) - TradingView
Bausch Health Companies Inc. Actuals & Estimates (TRADEGATE:BVF) - TradingView
Bausch Health Companies Inc. Actuals & Estimates (MUN:BVF) - TradingView
Price to earnings forward of Bausch Health Companies Inc. – FWB:BVF - TradingView
Bausch Health Companies Inc. Actuals & Estimates (NYSE:BHC) - TradingView
Bausch Health Companies Inc. Actuals & Estimates (FWB:BVF) - TradingView
Bausch Health Companies Inc. Actuals & Estimates (BOATS:BHC) - TradingView
Bausch Health Companies Inc. Actuals & Estimates (LSX:A2JQ1X) - TradingView
Bausch Health Companies Inc. Actuals & Estimates (BIVA:BHC/N) - TradingView
BHC Forecast — Price Target — Prediction for 2027 - TradingView
Bausch Health Companies adjusts debt profile, shares react to refinancing step - AD HOC NEWS
Price to earnings forward of Bausch Health Companies Inc. – BOATS:BHC - TradingView
Bausch Health Companies Inc (BHC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biotrue Hydration Boost Rehydrating Contact Lens Drops from Bausch Health Companiesquiet comfort - Ad-hoc-news.de
Can Bausch Health (TSX:BHC) Drive TSX Healthcare Stocks Higher? - Kalkine Media
Why Is Bausch Health (TSX:BHC) Expanding Its S&P/TSX Composite Footprint? - Kalkine Media
Bausch Health Cos (BHC) Institutional Ownership 2026 $BHC - MarketBeat
Bausch Health Companies Inc (BHC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bausch Health Companies Inc (BHC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bausch Health Companies Inc - TradingKey
Bausch Health’s Debt Strategy Shapes Its Market Narrative - Kalkine Media
Bausch Health Companies Inc (BHC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bausch Health Companies Inc (BHC) Institutional Confidence - TradingKey
Bausch Health Companies Inc (BHC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bausch Health Companies Inc (BHC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bausch Health Companies Inc (BHC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bausch Health stock hits 52-week low at 4.91 USD By Investing.com - Investing.com South Africa
Bausch Health stock hits 52-week low at 4.91 USD - Investing.com
Actinic Keratosis Market to Witness Transformational Growth Opportunities by 2036 – DelveInsight | Almirall, Biofrontera Pharma, Vidac Pharma, Rubedo Life Sciences, Bausch Health, Sandoz Pharma - Barchart.com
TSX Healthcare Stocks: Which Names Are Drawing Market Attention? - Kalkine Media
BHC Q1 2026 Earnings: EPS Surges 12.33% Above Estimates, Shares Edge HigherEarnings Surprise Score - newsline.com
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia - Cantech Letter
Why Bausch Health Companies Inc stock is sliding today - Wealth Awesome
Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7 - Moomoo
Bausch Health Companies Inc (BHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.04%
1.92%
자본화:
|
볼륨(24시간):